ReviewHuman

Neuroprotective and neuroregenerative drugs after severe traumatic brain injury : A narrative review from a clinical perspective

Wiener klinische Wochenschrift, 2024 Dec. Grgac I, Herzer G, Voelckel WG and 2 others.

Study type

Review

Subjects

Human participants (PubMed MeSH: Humans)

Journal

Wiener klinische Wochenschrift

Published

2024 Dec

PubMed

PMID 38748062 ↗

DOI

10.1007/s00508-024-02367-9 ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Cerebrolysin →

Indexed under

MeSH terms assigned by the National Library of Medicine.

HumansBrain Injuries, TraumaticNeuroprotective AgentsNerve Regeneration

Other papers on Cerebrolysin

Systematic review / meta-analysis · 2023

Cerebrolysin for acute ischaemic stroke

Systematic review / meta-analysis · 2019

Cerebrolysin for vascular dementia

Randomized controlled trial · 2025

Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page